This trial is evaluating whether SMART Study Intervention will improve 5 primary outcomes and 11 secondary outcomes in patients with Gynecologic Cancers. Measurement will happen over the course of 3-months.
This trial requires 140 total participants across 5 different treatment groups
This trial involves 5 different treatments. SMART Study Intervention is the primary treatment being studied. Participants will be divided into 5 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"Most cancers are rare--about 5000 in the US population a year. Oncologists use different levels of screening depending on their specialty and individual patient characteristics." - Anonymous Online Contributor
"Ovarian cancer affects more women than any other benign ovarian neoplasm. The most common form of ovarian cancer is serous carcinoma followed by endometrioid adenocarcinoma. Primary care physicians should be aware of the differential diagnosis of ovarian cancer." - Anonymous Online Contributor
"The treatment regimens for gynecologic cancer vary according to the primary histology; uterine, ovarian, and cervical cancers are largely managed by surgery. Radiotherapy is typically used to treat pelvic lymph nodes, but can also be used after surgery, depending on the stage of the disease. Tissue engineered techniques are being studied. Treatment of breast cancer varies by tumor type; surgery and radiation therapy are used if the tumor is early. Treatments for vulvar and vaginal cancer have improved in recent years. Surgery is the treatment of choice for anal cancer. When prostate cancer is the focus of treatment it is treated by radiation therapy, surgery, and chemotherapy." - Anonymous Online Contributor
"Gynecologic cancers, particularly cervical cancer, are relatively fast-growing cancers, resulting in high prevalence and great morbidity and mortality. In order to get this cancer diagnosed at an early stage before it becomes metastatic and inoperable, it is critical to have specific clinical findings and to be aware of symptoms that are seen in the early stages of this disease, especially for ovarian cancer and cervical cancer." - Anonymous Online Contributor
"Despite advances in surgical treatment over the last 40 years, the disease remains a progressive and difficult incurable disease for many patients. Despite this fact, the disease can be cured in the sense of prolonged survival." - Anonymous Online Contributor
"It appears that in the United States, the incidence of both endometrial and cervical cancers is increasing, and there is a correlation between the two, especially among the nulliparous women. However, at least two factors may be involved in this process. The first relates to the nulliparous woman and exposure to risk factors such as tobacco, alcohol, and a diet high in fat, protein, and/or sugar and also to the hormonal environment. The second relates to the incidence of premalignant lesions in the endometrium. When the incidence of such lesions in the endometrium in nulliparous women is plotted against the age of the woman, a gradual increase is seen as women become older." - Anonymous Online Contributor
"While overall, there are no new clinically approved Gynecologic Oncology Drugs (excluding hormonal therapy) and no new onco-genetics, there have been significant advances in the understanding of how these cancers interact (in an epigenetic fashion) with the [stroma surrounding them. These stromal components may be therapeutically exploited, which would represent a vast improvement." - Anonymous Online Contributor
"The advancement of research from clinical trials is fast. This enables patients to be better educated and better treated. As the quality of research continues to improve, so will advancements in research for gynecologic cancers. It is critical that patients are informed by the information and treatment that is available to pursue their healthcare." - Anonymous Online Contributor
"For this study, it was difficult to assess whether the group receiving the smart intervention had a better survival rate than the group receiving the placebo." - Anonymous Online Contributor
"The outcomes of gynecologic cancer surgery are poor. There are important ramifications of the disparity in outcomes depending on geographic location. Patients who live in rural areas who undergo major surgery for gynecologic cancer may experience significant morbidity and mortality. Strategies to expand access to adequate care and to improve outcomes for patients undergoing surgery for gynecologic cancer are needed." - Anonymous Online Contributor
"Smart study intervention is a strategy aiming to improve the quality of medical education. By changing the ways students participate in an intervention from passive observers to active actors, it is possible to increase their perceived relevance. Therefore, the quality of interventions for clinical practice would be [improved]. Students are [very] critical on their clinical reasoning on all levels. Findings from a recent study indicate that they would prefer to be more trained as smart study intervention teaches about the importance of [improving your clinical reasoning and reasoning skills, in order to be better physicians, nurses and health care specialists]." - Anonymous Online Contributor
"A clear family history exists in patients diagnosed with gynecologic cancers. However, if family history is present, it is less significant than in other types of cancers." - Anonymous Online Contributor